C. Favreau

发表

A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator.

M. Reboud-Ravaux, N. Boggetto, A. Vilain, 1991, Biochemical and biophysical research communications.

Mechanisms of fatty acid effects on sarcoplasmic reticulum. III. The effects of palmitic and oleic acids on sarcoplasmic reticulum function--a model for fatty acid membrane interactions.

J. Watras, H. Takenaka, C. Favreau, 1984, The Journal of biological chemistry.

Role of monocyte/macrophage derived matrix-metalloproteinases (gelatinases) in prolonged skin inflammation.

M. Reboud-Ravaux, J. Maillard, C. Favreau, 1995, Clinica chimica acta; international journal of clinical chemistry.

Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy.

C. Vigouroux, B. Buendia, J. Capeau, 2003, Experimental cell research.

Protection of vascular basement membrane and microcirculation from elastase-induced damage with a fluorinated beta-lactam derivative.

M. Reboud-Ravaux, J. Maillard, C. Favreau, 1992, Clinica chimica acta; international journal of clinical chemistry.

Plasminogen activation by normal B lymphocytes, a function associated with the cell membrane.

J. Maillard, C. Favreau, 1981, Journal of immunology.

Stimulated lymph node lymphocytes release a plasminogen activator.

J. Maillard, C. Favreau, F. Toullet, 1978, Annales d'immunologie.

Mechanisms of fatty acid effects on sarcoplasmic reticulum. II. Structural changes induced by oleic and palmitic acids.

J. Watras, L. Herbette, C. Favreau, 1984, The Journal of biological chemistry.

Cell cycle-dependent phosphorylation of nucleoporins and nuclear pore membrane protein Gp210.

R. Wozniak, H. Worman, J. Courvalin, 1996, Biochemistry.

Biochemical characterization of nuclear pore complex protein gp210 oligomers.

J. Cartaud, J. Courvalin, P. Mustonen, 2001, European journal of biochemistry.

Expression of a Mutant Lamin A That Causes Emery-Dreifuss Muscular Dystrophy Inhibits In Vitro Differentiation of C2C12 Myoblasts

B. Buendia, J. Courvalin, C. Favreau, 2004, Molecular and Cellular Biology.

Differentiation of C2C12 myoblasts expressing lamin A mutated at a site responsible for Emery-Dreifuss muscular dystrophy is improved by inhibition of the MEK-ERK pathway and stimulation of the PI3-kinase pathway.

E. Delbarre, B. Buendia, J. Courvalin, 2008, Experimental cell research.

Reaction of thrombin and proteinases of the fibrinolytic system with a mechanism-based inhibitor, 3,4-dihydro-3-benzyl-6-chloromethylcoumarin.

M. Reboud-Ravaux, J. Maillard, C. Favreau, 1990, Biochimica et biophysica acta.

Differentiation of C2C12 myoblasts expressing lamin A mutated at a site responsible for Emery-Dreifuss muscular dystrophy is improved by inhibition of the MEK-ERK pathway and stimulation of the PI3-kinase pathway.

E. Delbarre, B. Buendia, J. Courvalin, 2008, Experimental cell research.

Specific and nonspecific channels leading to proteolysis in antibody preparations.

J. Maillard, C. Favreau, 1975, British journal of experimental pathology.